Peter F. Troke

10.5k total citations · 1 hit paper
49 papers, 5.3k citations indexed

About

Peter F. Troke is a scholar working on Infectious Diseases, Epidemiology and Small Animals. According to data from OpenAlex, Peter F. Troke has authored 49 papers receiving a total of 5.3k indexed citations (citations by other indexed papers that have themselves been cited), including 42 papers in Infectious Diseases, 27 papers in Epidemiology and 8 papers in Small Animals. Recurrent topics in Peter F. Troke's work include Antifungal resistance and susceptibility (41 papers), Fungal Infections and Studies (24 papers) and Infectious Diseases and Mycology (7 papers). Peter F. Troke is often cited by papers focused on Antifungal resistance and susceptibility (41 papers), Fungal Infections and Studies (24 papers) and Infectious Diseases and Mycology (7 papers). Peter F. Troke collaborates with scholars based in United Kingdom, United States and France. Peter F. Troke's co-authors include T. J. Flowers, A. R. Yeo, William Hope, Kenneth Richardson, Timothy Felton, Elizabeth M. Johnson, Irja Lutsar, M. S. Marriott, Christopher A. Hitchcock and S. J. Roffey and has published in prestigious journals such as Blood, PLoS ONE and Clinical Microbiology Reviews.

In The Last Decade

Peter F. Troke

48 papers receiving 5.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The Mechanism of Salt Tolerance in Halophytes

1977 1.5k citations Peter F. Troke et al. profile →

Peers

Countries citing papers authored by Peter F. Troke

Since Specialization

Citations

This map shows the geographic impact of Peter F. Troke's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter F. Troke with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter F. Troke more than expected).

Fields of papers citing papers by Peter F. Troke

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter F. Troke. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter F. Troke. The network helps show where Peter F. Troke may publish in the future.

Co-authorship network of co-authors of Peter F. Troke

This figure shows the co-authorship network connecting the top 25 collaborators of Peter F. Troke. A scholar is included among the top collaborators of Peter F. Troke based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter F. Troke. Peter F. Troke is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Fluconazole: Its Properties and Efficacy in Vaginal Candidiasis 2015 ·Current problems in dermatology ·Peter F. Troke	0
2	Tissue Penetration of Antifungal Agents 2014 ·Clinical Microbiology Reviews ·Timothy Felton, Peter F. Troke, William Hope	279
3	Voriconazole or Amphotericin B as Primary Therapy Yields Distinct Early Serum Galactomannan Trends Related to Outcomes in Invasive Aspergillosis 2014 ·PLoS ONE ·Louis Yi Ann Chai, Bart Jan Kullberg, Arul Earnest, Elizabeth M. Johnson, Steven Teerenstra, Alieke G. Vonk, Haran T. Schlamm, Raoul Herbrecht, Mihai G. Netea, Peter F. Troke	17
4	An elevated pro-inflammatory cytokine response is linked to development of amphotericin B-induced nephrotoxicity 2013 ·Journal of Antimicrobial Chemotherapy ·Louis Yi Ann Chai, Mihai G. Netea, Bee Choo Tai, Lay‐Wai Khin, Alieke G. Vonk, Boon Wee Teo, (unknown), Raoul Herbrecht, J. Peter Donnelly, Peter F. Troke, Bart Jan Kullberg	19
5	The efficacy of voriconazole in 24 ocular Fusarium infections 2012 ·Infection ·Peter F. Troke, (unknown), T. Gaujoux, P. Goldschmidt, Anne‐Lise Bienvenu, Muriel Cornet, Frédéric Grenouillet, (unknown), Stéphane Ranque, Karine Sitbon, C. Chaumeil, Vincent Borderie, Olivier Lortholary	20
6	Association of Mannose‐Binding Lectin Deficiency with Acute Invasive Aspergillosis in Immunocompromised Patients 2009 ·Clinical Infectious Diseases ·Jonathan Lambourne, Dan Agranoff, Raoul Herbrecht, Peter F. Troke, Aby Buchbinder, Fenella Willis, Valérie Letscher‐Bru, Samir Agrawal, Sarah Doffman, Elizabeth M. Johnson, (unknown), Rosemary A. Barnes, George E. Griffin, Jodi A. Lindsay, Thomas S. Harrison	61
7	Activities of voriconazole, itraconazole and amphotericin B in vitro against 590 moulds from 323 patients in the voriconazole Phase III clinical studies 2008 ·Journal of Antimicrobial Chemotherapy ·Ana Espinel-Ingroff, Elizabeth M. Johnson, (unknown), Peter F. Troke	73
8	Activity of voriconazole, itraconazole, fluconazole and amphotericin B in vitro against 1763 yeasts from 472 patients in the voriconazole phase III clinical studies 2008 ·International Journal of Antimicrobial Agents ·Elizabeth M. Johnson, Ana Espinel‐Ingroff, Adrien Székely, (unknown), Peter F. Troke	29
9	Imaging Findings in Acute Invasive Pulmonary Aspergillosis: Clinical Significance of the Halo Sign 2007 ·Clinical Infectious Diseases ·Reginald E. Greene, (unknown), J W Oestmann, Paul Stark, Christine M. Durand, Olivier Lortholary, John R. Wingard, Raoul Herbrecht, Patricia Ribaud, Thomas F. Patterson, Peter F. Troke, David W. Denning, John E. Bennett, B.E. de Pauw, R H Rubin	394
10	Poor efficacy of amphotericin B‐based therapy in CNS aspergillosis 2007 ·Mycoses ·Stefan Schwartz, Markus Ruhnke, Patricia Ribaud, Elizabeth Reed, Peter F. Troke, Eckhard Thiel	40
11	Investigation of the Potential Relationships Between Plasma Voriconazole Concentrations and Visual Adverse Events or Liver Function Test Abnormalities 2006 ·The Journal of Clinical Pharmacology ·Keith Tan, (unknown), Konrad E. Tomaszewski, Peter F. Troke, Nolan Wood	198
12	Strategy of Following Voriconazole versus Amphotericin B Therapy with Other Licensed Antifungal Therapy for Primary Treatment of Invasive Aspergillosis: Impact of Other Therapies on Outcome 2005 ·Clinical Infectious Diseases ·Thomas F. Patterson, Helen W. Boucher, Raoul Herbrecht, David W. Denning, Olivier Lortholary, Patricia Ribaud, R H Rubin, John R. Wingard, Ben E. dePauw, Haran T. Schlamm, Peter F. Troke, John E. Bennett	65
13	Economic evaluation of voriconazole compared with conventional amphotericin B for the primary treatment of aspergillosis in immunocompromised patients 2005 ·Journal of Antimicrobial Chemotherapy ·Richard P. Wenzel, A. Del Favero, C C Kibbler, Thomas R. Rogers, Coleman Rotstein, Josephine Mauskopf, Stephen Morris, Haran T. Schlamm, Peter F. Troke, (unknown)	59
14	Voriconazole Concentrations in the Cerebrospinal Fluid and Brain Tissue of Guinea Pigs and Immunocompromised Patients 2003 ·Clinical Infectious Diseases ·Irja Lutsar, S. J. Roffey, Peter F. Troke	196
15	A Randomized, Double‐Blind, Double‐Dummy, Multicenter Trial of Voriconazole and Fluconazole in the Treatment of Esophageal Candidiasis in Immunocompromised Patients 2001 ·Clinical Infectious Diseases ·R. Ally, Dirk Schürmann, Wolfgang Kreisel, Giampiero Carosi, Koldo Aguirrebengoa, B. Dupont, Michael R. Hodges, Peter F. Troke, Alain Romero, (unknown)	223
16	Large-scale multicentre study of fluconazole in the treatment of hospitalised patients with fungal infections 1997 ·European Journal of Clinical Microbiology & Infectious Diseases ·Peter F. Troke	11
17	HIV-1 proteinase is required for synthesis of pro-viral DNA 1991 ·Biochemical and Biophysical Research Communications ·C. Baboonian, Angus Dalgleish, Lynne Bountiff, (unknown), Stephen Oroszlan, (unknown), Caroline Smith‐Burchnell, Peter F. Troke, James Merson	45
18	Fluconazole and Other Azoles: Translation of in Vitro Activity to in Vivo and Clinical Efficacy 1990 ·Clinical Infectious Diseases ·Peter F. Troke, R. J. Andrews, (unknown), Kenneth Richardson	48
19	Design and Evaluation of a Systemically Active Agent, Fluconazole 1988 ·Annals of the New York Academy of Sciences ·Kenneth Richardson, Keith Cooper, M. S. Marriott, Michael H. Tarbit, Peter F. Troke, P. J. WHITTLE	35
20	In Vitro Potency and in Vivo Activity of Azoles 1988 ·Annals of the New York Academy of Sciences ·Peter F. Troke, M. S. Marriott, Kenneth Richardson, Michael H. Tarbit	29

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact